Dextroamphetamine-Cocaine Behavioral Intervention - 5
Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Dextroamphetamine (Drug); D-amphetamine (Drug); placebo (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: National Institute on Drug Abuse (NIDA) Official(s) and/or principal investigator(s):
John Grabowski, Ph.D., Principal Investigator, Affiliation: University of Texas
Summary
The purpose of this study is to examine dextroamphetamine-cocaine behavioral intervention in
cocaine dependent patients.
Clinical Details
Official title: D-Amphetamine-Cocaine Behavioral Intervention
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Verifiable cocaine abstinence
Eligibility
Minimum age: 18 Years.
Maximum age: 45 Years.
Gender(s): Both.
Criteria:
Please contact site for information.
Locations and Contacts
University of Texas Health Science Center, Houston, Texas 77225, United States
Additional Information
Starting date: September 1995
Last updated: August 18, 2008
|
